Last reviewed · How we verify
SR147778
At a glance
| Generic name | SR147778 |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE) (PHASE2)
- A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SR147778 CI brief — competitive landscape report
- SR147778 updates RSS · CI watch RSS
- Sanofi portfolio CI